Prostate cancer treatment deintensification: When less is more.

PROSTATE tumors treatment; DISEASE progression; ANTIANDROGENS; INDIVIDUALIZED medicine; TREATMENT effectiveness; RISK assessment; ADVERSE health care events; DISEASE management; PROSTATE tumors; OVERALL survival

In the article, the author discusses updates in the treatment of patients with advanced and metastatic prostate cancer, particularly the clinical trials showing the efficacy of treatment deintensification in the proper clinical context. Other topics include the potential benefits of deintensification like reduction of treatment-related adverse events (TRAE) and the various deintensification methods like radiation therapy with omission of androgen deprivation therapy (ADT).